跳至主要内容
临床试验/NCT00168129
NCT00168129已完成1 期

Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases

Alberta Health services1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2001年6月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
1
主要终点
To deliver a single fraction of radiotherapy safely to patients with bone metastases using helical tomotherapy

研究概览

简要总结

To assess the safety and efficacy of a single fraction of radiotherapy using helical tomotherapy to treat bone metastases.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •painful metastatic bone disease from any malignancy

排除标准

  • •previous RT to same area
  • •contraindications to RT

结局指标

主要结局

To deliver a single fraction of radiotherapy safely to patients with bone metastases using helical tomotherapy

次要结局

  • To assess and quantify the acute toxicity of patients with bone metastases treated with helical tomotherapy.
  • To measure invivo dosimetry and compare delivered doses to computer-reconstructed dose distribution.
  • To determine the maximum tolerated does of palliative radiation give with helical tomotherapy in a single fraction.
  • To assess the efficacy (pain control) of radiotherapy given with helical tomotherapy.

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验